NCT05230303 is a NA clinical trial of Caffeine supplementation in Caffeine, sponsored by The Jerzy Kukuczka Academy of Physical Education in Katowice.

Who is sponsoring NCT05230303?

NCT05230303 is sponsored by The Jerzy Kukuczka Academy of Physical Education in Katowice.

What drugs are being tested in NCT05230303?

Interventions in NCT05230303: Caffeine supplementation, Placebo treatment.

Is NCT05230303 still recruiting?

NCT05230303 is currently completed. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT05230303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Caffeine Supplementation, Resistance Training and Blood Antioxidant Status

Completed NA Last updated 10 March 2023

What this trial tests

NA trial testing Caffeine supplementation in Caffeine in 15 participants. Completed in 31 January 2023.

Timeline

12 January 2022

Primary endpoint
31 January 2023

31 January 2023

Quick facts

Lead sponsor	The Jerzy Kukuczka Academy of Physical Education in Katowice
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	15
Start date	12 January 2022
Primary completion	31 January 2023
Estimated completion	31 January 2023
Sites	1 location across Poland

Drugs / interventions tested

Caffeine supplementation
Placebo treatment

Conditions studied

Caffeine — all drugs for Caffeine →

Sponsor

The Jerzy Kukuczka Academy of Physical Education in Katowice

Who can join

Adults 18 to 45, male only, with Caffeine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to verify the effect of acute caffeine intake on resistance training volume and blood antioxidant status, in a randomised, double-blind, placebo-controlled crossover trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Acute Caffeine Intake on Resistance Training Volume, Prooxidant-Antioxidant Balance and Muscle Damage Markers Following a Session of Full-Body Resistance Exercise in Resistance-Trained Men Habituated to Caffeine.
Filip-Stachnik A, Krzysztofik M, Del Coso J, Pałka T, et al · · 2023 · cited 2× · PMID 37711718 · DOI 10.52082/jssm.2023.436

Verify or expand the search:

Other trials of Caffeine supplementation

Trials testing the same drug.

NCT04642131 — Effect of Caffeine Supplementation and Personalized Insoles on Females · NA · suspended
NCT03822663 — The Influence of Caffeine Supplementation on Specific Performance and Training Activities · Phase 3 · completed

Other recruiting trials for Caffeine

Currently open trials in the same condition.

NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
NCT07404254 — Effects of Variations in Caffeinated Beverages on Well-being · NA · recruiting
NCT06763172 — Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI · Phase 4 · recruiting
NCT05325502 — Does Caffeine Facilitate Human Reward Learning Behaviors? · NA · active not recruiting
NCT05454332 — The Caffeine Therapy in the Fetal to Neonatal Transition · Phase 4 · recruiting

Other The Jerzy Kukuczka Academy of Physical Education in Katowice trials

Trials by the same sponsor.

NCT07482254 — Acute Effects of Isometric Conditioning on Sprint, Jump and Change of Direction Performance in Youth Soccer Players · NA · enrolling by invitation
NCT07297251 — Temporomandibular Joints Mobility and Head Posture: Influence of Manual Therapy and Exercises in Dental Patients. · NA · not yet recruiting
NCT07483931 — Priming Magnitude and Retention in Highly Trained Male Volleyball Players · NA · completed
NCT06959329 — Influence of Sensory Stimulation on Sensory Parameters and Motor Function in Children With Developmental Coordination Di · NA · not yet recruiting
NCT06982937 — Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Rando · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05230303 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Jerzy Kukuczka Academy of Physical Education in Katowice
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05230303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing